Ruoyang Liu
Key Laboratory Of Urinary Tumors
Zhengzhou, China
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Docetaxel induced activation of GSDME pathway and pyroptosis enhance immune lethality in prostate cancer cells.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 21, 2025
Targeted inhibition of the CREB1-CtIP axis enhances the efficacy of abiraterone combined with radiotherapy in prostate cancer.
Journal: Cell death & disease
Published: July 14, 2025
CXCL12/CXCR4 axis governs Treg spatial dominance over CD8+ T cells via IL-2 sequestration: a dual therapeutic target in prostate cancer.
Journal: Frontiers in immunology
Published: May 11, 2025
The Oncopromoting Gene RBM6 Inhibits Prostate Tumour Cell Migration During Epithelial-to-Mesenchymal Transition.
Journal: Journal of cellular and molecular medicine
Published: November 29, 2024
Phosphatase LHPP confers prostate cancer ferroptosis activation by modulating the AKT-SKP2-ACSL4 pathway.
Journal: Cell death & disease
Published: April 16, 2024
Enzalutamide inhibits PEX10 function and sensitizes prostate cancer cells to ROS activators.
Journal: Cell death & disease
Published: March 01, 2024
SYT4 binds to SNAP25 to facilitate exosomal secretion and prostate cancer enzalutamide resistance.
Journal: Cancer science
Published: January 12, 2024
8-Br-cGMP activates HSPB6 and increases the antineoplastic activity of quinidine in prostate cancer.
8-Br-cGMP activates HSPB6 and increases the antineoplastic activity of quinidine in prostate cancer.
Journal: Cell death discovery
Published: September 23, 2023
TrkA promotes MDM2-mediated AGPS ubiquitination and degradation to trigger prostate cancer progression.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 14, 2023
PDE3B regulates KRT6B and increases the sensitivity of bladder cancer cells to copper ionophores.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: August 13, 2023
ANXA13 promotes cell proliferation and invasion and attenuates apoptosis in renal cell carcinoma.
Journal: Heliyon
Published: September 15, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026